Ligand Pharmaceuticals reported 298K in Interest Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Arrowhead Research ARWR:US 1.24M 186K
Baxter International BAX:US 4M 1000K
Eli Lilly LLY:US 10.2M 3.2M
Endo International ENDP:US 147K 21K
Harsco HSC:US 693K 49K
Intrexon XON:US 37K 397K
Karyopharm Therapeutics KPTI:US 293K 219K
Ligand Pharmaceuticals LGND:US 298K 164K
Pacira PCRX:US 252K 19K
Pfizer PFE:US 30M 16M
Rigel Pharmaceuticals RIGL:US 42K 21K
Sangamo BioSciences SGMO:US 2.64M 1.3M
Spectrum Pharmaceuticals SPPI:US 117K 106K
Veracyte VCYT:US 212K 173K